Method of producing polymorphic crystals of donepezil hydrochloride
AssigneeEisai R&D Management Co., Ltd.
InventorsAkio Imai, Akihiko Shimotani
Life of this patent
Estimating the term…
Abstract
The present invention provides a simple method of producing polymorphic crystal (III), which has high safety to environment and the bodies of operators; is gentle to environment; and can produce at low costs; and has a high refining effect. It is a method of producing polymorphic crystal (III) of donepezil hydrochloride (chemical name: 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine•monohydrochloride) represented by the following structural formula (formula (I)), which comprises dissolving donepezil (chemical name: 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) in ethanol; and adding hydrochloric acid or hydrogen chloride thereto, followed by stirring.
Claims5
A method of producing a crystalline form (III) of donepezil hydrochloride (chemical name:
- 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine•monohydrochioride) represented by the following structural formula 1:
- by the steps of:
- dissolving donepezil (chemical name:
- 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) in ethanol;
- adding hydrochloric acid or hydrogen chloride thereto;
- stirring while keeping the internal temperature at 10 to 40° C.;
- and
- then collecting by filtration and drying the resulting crystals;
- wherein the crystalline form (III) of donepezil hydrochloride is a crystalline form having peaks at the following diffraction angles (2θ) in its powder X-ray diffraction patterns;
- TABLE 1
- Diffraction angle
- (2θ°)
- Intensity (I/Io)
- 6.56
- 30
- 9.94
- 8
- 13.00
- 17
- 15.00
- 47
- 15.26
- 14
- 15.74
- 6
- 16.48
- 35
- 17.42
- 4
- 18.10
- 21
- 18.50
- 56
- 19.50
- 17
- 20.10
- 32
- 20.94
- 21
- 21.66
- 100
- 22.32
- 25
- 22.92
- 17
- 23.92
- 19
- 24.68
- 17
- 26.00
- 44
- 27.20
- 23
- 28.02
- 29
- 28.22
- 40
- 28.60
- 13
- with absorption at the following wave numbers in its infrared absorption spectrum in potassium bromide:
- 559, 641, 648, 702, 749, 765, 786, 807, 851, 872, 927, 949, 966, 975, 982, 1007, 1034, 1071, 1080, 1111, 1119, 1131, 1177, 1190, 1205, 1217, 1230, 1250, 1265, 1292, 1313, 1367, 1389, 1420, 1438, 1453, 1461, 1470, 1500, 1589, 1605, 1697, 2407,2419, 2461, 2624, 2641, 2651, 2667, 2837, 2848, 2873, 2924, 2954, 2961, 2993, 3007, 3377, 3433 cm−1;
- or a crystalline form having peaks at the following diffraction angles (2θ) in its powder X-ray diffraction patterns;
- TABLE 2
- Diffraction angle
- (2θ°)
- Intensity (I/Io)
- 6.48
- 21
- 9.84
- 7
- 12.96
- 19
- 14.94
- 45
- 15.20
- 13
- 16.44
- 31
- 18.04
- 20
- 18.46
- 55
- 19.44
- 17
- 20.02
- 30
- 20.86
- 20
- 21.02
- 13
- 21.58
- 100
- 22.22
- 23
- 22.90
- 15
- 23.92
- 13
- 24.64
- 15
- 25.92
- 40
- 26.18
- 17
- 27.14
- 21
- 28.14
- 37
- 28.56
- 11
- 29.94
- 12
- with absorption at the following wave numbers in its infrared absorption spectrum in potassium bromide:
- 558.3, 641.1, 702.4, 748.5, 765.0, 786.1, 807.3, 850.8, 872.0, 926.8, 974.9, 1034.1, 1071.5, 1111.6, 1190.1, 1216.6, 1265.4, 1291.9, 1312.9, 1364.4, 1420.2, 1438.1, 1458.8, 1499.1, 1522.2, 1542.6, 1560.1, 1570.2, 1589.1, 1638.8, 1647.8, 1654.3, 1697.3, 1718.1, 1734.5, 1751.4, 1773.7, 1793.5, 1845.8, 2345.3, 2461.6, 2924.2, 3447.9 cm−1.
Dependencies are inferred from the claim text.